Education
About Us
Working with TipRanks
Follow Us
Viatris (DE:VIA)
XETRA:VIA
Earnings Data
Report Date
Nov 10, 2025Before Open (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
0.53Last Year’s EPS
0.64Same Quarter Last Year
Moderate Sell
Based on 3 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call presented a mix of strong pipeline progress and international growth, particularly in China, alongside challenges related to operational impacts from the Indore facility and declines in the North American and Japanese markets. Despite these challenges, the company's focus on shareholder returns and upcoming product launches suggests potential for future growth.Company Guidance -
Q3 2025
Strong Pipeline Progress
Significant progress in the pipeline with 5 out of 6 anticipated Phase III readouts showing positive results, including two ophthalmology programs and a fast-acting formulation of meloxicam targeting an $80 billion U.S. acute pain market.
Operational Revenue Growth
Achieved 3% divestiture-adjusted operational revenue growth, primarily driven by strong performance in Europe and Greater China.
Shareholder Returns
Returned over $630 million to shareholders, including $350 million in share repurchases so far this year.
Positive Developments in China
Greater China net sales grew 9%, exceeding expectations due to strong demand and proactive patient choice.
New Product Launches Expected
Multiple product launches anticipated in 2026, including EFFEXOR for generalized anxiety disorder in Japan, XULANE low dose for contraception, and several ophthalmology products.
DE:VIA Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:VIA Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 07, 2025 | €7.63 | €7.65 | +0.24% |
May 08, 2025 | €7.51 | €8.18 | +8.89% |
Feb 27, 2025 | €10.53 | €8.79 | -16.49% |
Nov 07, 2024 | €10.58 | €11.63 | +9.98% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Viatris (DE:VIA) report earnings?
Viatris (DE:VIA) is schdueled to report earning on Nov 10, 2025, Before Open (Confirmed).
What is Viatris (DE:VIA) earnings time?
Viatris (DE:VIA) earnings time is at Nov 10, 2025, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Viatris stock?
The P/E ratio of Viatris is N/A.
What is DE:VIA EPS forecast?
DE:VIA EPS forecast for the fiscal quarter 2025 (Q3) is 0.53.
